← All organizations
Highest phase reached
Phase 4
Acquired by Asahi Kasei Pharma on Nov 26, 2019
Timeline
2000s
- Jul 1, 2002
Veloxis Pharmaceuticals— Founded
2010s
- Jul 10, 2015
tacrolimus— NDA Secondary Org
- Nov 26, 2019
Asahi Kasei Pharma— Acquired By
Drugs by trial phase (13 distinct, 38 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (43)
- NCT07290777Lead sponsorPhase 2Jul 31, 2026
- NCT06751992CollaboratorPhase 4May 1, 2025
- NCT05238493Lead sponsorPhase 1Apr 26, 2022
- NCT05238493Study directorPhase 1Apr 26, 2022
- NCT05251727Study directorPhase 1Mar 24, 2022
- NCT05251727Lead sponsorPhase 1Mar 24, 2022
- NCT04917718CollaboratorPhase 4Sep 1, 2021
- NCT04838288CollaboratorPhase 4Jun 22, 2021
- NCT04773392CollaboratorPhase 4Feb 28, 2021
- NCT04711291CollaboratorN/AJan 11, 2021
- NCT04469842CollaboratorEarly Phase 1Nov 30, 2020
- NCT04225988CollaboratorPhase 4Jan 9, 2020
- NCT03823768CollaboratorPhase 4Sep 1, 2019
- NCT03979365CollaboratorPhase 4Jul 1, 2019
- NCT03841097CollaboratorPhase 4Jun 30, 2019
Details
- Founded
- Horsholm, DK Jul 1, 2002
- Last known activity
- Jul 31, 2026
Notes
Formerly known as LifeCycle Pharma